JP2023549712A - ニューロメラニン感受性ｍｒｉ及びその使用方法 - Google Patents

ニューロメラニン感受性ｍｒｉ及びその使用方法 Download PDF

Info

Publication number
JP2023549712A
JP2023549712A JP2023526396A JP2023526396A JP2023549712A JP 2023549712 A JP2023549712 A JP 2023549712A JP 2023526396 A JP2023526396 A JP 2023526396A JP 2023526396 A JP2023526396 A JP 2023526396A JP 2023549712 A JP2023549712 A JP 2023549712A
Authority
JP
Japan
Prior art keywords
neuromelanin
disease
mri
alzheimer
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023526396A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022104288A5 (https=
JP2023549712A5 (https=
Inventor
クラーク，サミュエル
キャシディ，クリフォード
ローザ－ネト，ペドロ
ウェングラー，ケネス
ヘルナンデス，ギリェルモ ホルガ
Original Assignee
テラン バイオサイエンシズ， インコーポレイテッド
ユニバーシティ オブ オタワ インスティテュート オブ メンタル ヘルス リサーチ
ザ ロイヤル インスティテューション フォー ザ アドバンスメント オブ ラーニング／マクギル ユニバーシティ
ザ トラスティーズ オブ コロンビア ユニバーシティー イン ザ シティー オブ ニューヨーク
ザ リサーチ ファウンデーション フォー メンタル ハイジーン インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by テラン バイオサイエンシズ， インコーポレイテッド, ユニバーシティ オブ オタワ インスティテュート オブ メンタル ヘルス リサーチ, ザ ロイヤル インスティテューション フォー ザ アドバンスメント オブ ラーニング／マクギル ユニバーシティ, ザ トラスティーズ オブ コロンビア ユニバーシティー イン ザ シティー オブ ニューヨーク, ザ リサーチ ファウンデーション フォー メンタル ハイジーン インコーポレイテッド filed Critical テラン バイオサイエンシズ， インコーポレイテッド
Publication of JP2023549712A publication Critical patent/JP2023549712A/ja
Publication of JPWO2022104288A5 publication Critical patent/JPWO2022104288A5/ja
Publication of JP2023549712A5 publication Critical patent/JP2023549712A5/ja
Priority to JP2025273972A priority Critical patent/JP2026066253A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/40—Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
    • A61B5/4088—Diagnosing of monitoring cognitive diseases, e.g. Alzheimer, prion diseases or dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
    • A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H30/00—ICT specially adapted for the handling or processing of medical images
    • G16H30/20—ICT specially adapted for the handling or processing of medical images for handling medical images, e.g. DICOM, HL7 or PACS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0033—Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room
    • A61B5/004—Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room adapted for image acquisition of a particular organ or body part
    • A61B5/0042—Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room adapted for image acquisition of a particular organ or body part for the brain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4842—Monitoring progression or stage of a disease
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H30/00—ICT specially adapted for the handling or processing of medical images
    • G16H30/40—ICT specially adapted for the handling or processing of medical images for processing medical images, e.g. editing
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pathology (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Data Mining & Analysis (AREA)
  • Psychology (AREA)
  • Child & Adolescent Psychology (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Psychiatry (AREA)
  • Developmental Disabilities (AREA)
  • Neurosurgery (AREA)
  • Physiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Databases & Information Systems (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nuclear Medicine (AREA)
JP2023526396A 2020-11-16 2021-11-16 ニューロメラニン感受性ｍｒｉ及びその使用方法 Pending JP2023549712A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025273972A JP2026066253A (ja) 2020-11-16 2025-12-22 ニューロメラニン感受性ｍｒｉ及びその使用方法

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202063114304P 2020-11-16 2020-11-16
US63/114,304 2020-11-16
US202063120105P 2020-12-01 2020-12-01
US63/120,105 2020-12-01
US202163277490P 2021-11-09 2021-11-09
US63/277,490 2021-11-09
PCT/US2021/059590 WO2022104288A1 (en) 2020-11-16 2021-11-16 Neuromelanin-sensitive mri and methods of use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025273972A Division JP2026066253A (ja) 2020-11-16 2025-12-22 ニューロメラニン感受性ｍｒｉ及びその使用方法

Publications (3)

Publication Number Publication Date
JP2023549712A true JP2023549712A (ja) 2023-11-29
JPWO2022104288A5 JPWO2022104288A5 (https=) 2024-11-26
JP2023549712A5 JP2023549712A5 (https=) 2024-11-26

Family

ID=81602654

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2023526396A Pending JP2023549712A (ja) 2020-11-16 2021-11-16 ニューロメラニン感受性ｍｒｉ及びその使用方法
JP2025273972A Pending JP2026066253A (ja) 2020-11-16 2025-12-22 ニューロメラニン感受性ｍｒｉ及びその使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025273972A Pending JP2026066253A (ja) 2020-11-16 2025-12-22 ニューロメラニン感受性ｍｒｉ及びその使用方法

Country Status (9)

Country Link
US (1) US20230389854A1 (https=)
EP (1) EP4243684A4 (https=)
JP (2) JP2023549712A (https=)
KR (1) KR20230131180A (https=)
AU (1) AU2021377338A1 (https=)
CA (1) CA3199469A1 (https=)
IL (1) IL302831A (https=)
MX (1) MX2023005649A (https=)
WO (1) WO2022104288A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230281804A1 (en) * 2020-07-31 2023-09-07 Koninklijke Philips N.V. Landmark detection in medical images
JP2024510080A (ja) 2021-03-11 2024-03-06 テラン バイオサイエンシズ インコーポレイテッド バイオマーカーを含む撮像データセットのハーモナイゼーションのためのシステム、デバイス及び方法
TW202333668A (zh) 2021-12-15 2023-09-01 美商德利克斯醫療公司 經苯氧基及苄氧基取代之精神成形素(psychoplastogen)及其用途
WO2023235766A2 (en) * 2022-05-31 2023-12-07 University Of Ottawa Institute Of Mental Health Research Methods for acquiring and analyzing neuromelanin-sensitive mri
CN117095815B (zh) * 2023-07-20 2025-05-27 中国人民解放军海军军医大学第一附属医院 基于磁共振图像和病理全景扫描切片预测带有同源重组缺陷的前列腺癌患者的系统
CN117078638A (zh) * 2023-08-22 2023-11-17 深圳湾实验室 一种图像处理方法、装置及电子设备
TWI877875B (zh) * 2023-10-31 2025-03-21 中國醫藥大學附設醫院 腦部斷層掃描電腦輔助偵測系統、方法及電腦程式產品
CN117690537B (zh) * 2024-02-04 2024-06-18 中日友好医院(中日友好临床医学研究所) Qsm与脑萎缩、脑连接组关联的跨模态方法及装置

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150125057A1 (en) * 2012-05-04 2015-05-07 Emory University Methods, systems and computer readable storage media storing instructions for imaging and determining information associated with regions of the brain
WO2019098714A1 (ko) * 2017-11-17 2019-05-23 울산과학기술원 뇌에 존재하는 철의 시각화를 위한 방법
WO2020077098A1 (en) * 2018-10-10 2020-04-16 The Trustees Of Columbia University In The City Of New York System, method and computer-accessible medium for neuromelanin-sensitive magnetic resonance imaging as a non-invasive proxy measure of dopamine function in the human brain
CN111681184A (zh) * 2020-06-09 2020-09-18 复旦大学附属华山医院 一种神经黑色素图像重建方法、装置、设备和存储介质

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6288545B1 (en) * 1999-03-22 2001-09-11 General Electric Company Method and apparatus for calibration of RF and gradient field time delays
EP3766042B1 (en) * 2018-03-14 2025-05-07 Emory University Systems and methods for generating biomarkers based on multivariate mri and multimodality classifiers for disorder diagnosis

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150125057A1 (en) * 2012-05-04 2015-05-07 Emory University Methods, systems and computer readable storage media storing instructions for imaging and determining information associated with regions of the brain
WO2019098714A1 (ko) * 2017-11-17 2019-05-23 울산과학기술원 뇌에 존재하는 철의 시각화를 위한 방법
WO2020077098A1 (en) * 2018-10-10 2020-04-16 The Trustees Of Columbia University In The City Of New York System, method and computer-accessible medium for neuromelanin-sensitive magnetic resonance imaging as a non-invasive proxy measure of dopamine function in the human brain
CN111681184A (zh) * 2020-06-09 2020-09-18 复旦大学附属华山医院 一种神经黑色素图像重建方法、装置、设备和存储介质

Also Published As

Publication number Publication date
AU2021377338A9 (en) 2024-09-12
AU2021377338A1 (en) 2023-06-01
EP4243684A1 (en) 2023-09-20
KR20230131180A (ko) 2023-09-12
JP2026066253A (ja) 2026-04-16
WO2022104288A1 (en) 2022-05-19
MX2023005649A (es) 2023-09-27
CA3199469A1 (en) 2022-05-19
EP4243684A4 (en) 2025-03-12
IL302831A (en) 2023-07-01
US20230389854A1 (en) 2023-12-07

Similar Documents

Publication Publication Date Title
US20230389854A1 (en) Neuromelanin-sensitive mri and methods of use thereof
US20260007323A1 (en) Neuromelanin-sensitive mri for assessing parkinson's disease
Landin-Romero et al. Disease-specific patterns of cortical and subcortical degeneration in a longitudinal study of Alzheimer's disease and behavioural-variant frontotemporal dementia
Guzman et al. White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment
Walker et al. Lewy body dementias
Sorbi et al. EFNS‐ENS Guidelines on the diagnosis and management of disorders associated with dementia
Tripathi et al. Differential diagnosis of neurodegenerative dementias using metabolic phenotypes on F-18 FDG PET/CT
David et al. New approaches for the quantification and targeting of noradrenergic dysfunction in Alzheimer's disease
US10534052B2 (en) FMRI biomarker of neurodegenerative disease
Tuovinen Investigating BOLD signal variability and its physiological signal sources in Alzheimer's disease, behavioral variant frontotemporal dementia, and schizophrenia
Tosun et al. Profiling and predicting distinct tau progression patterns: An unsupervised data‐driven approach to flortaucipir positron emission tomography
Linden Neuroimaging and neurophysiology in psychiatry
Trojan et al. Brain volume and fatigue in patients with postpoliomyelitis syndrome
Zhu et al. Impaired frontolimbic connectivity and depressive symptoms in patients with Alzheimer's disease
CN116745858A (zh) 神经黑色素敏感性mri及其使用方法
Cecil Effects of early low-level lead exposure on human brain structure, organization and functions
Liu et al. Esketamine combined with sertraline for brain Altered Regional Homogeneity in patients with major depressive disorder: a preliminary study
Meadowcroft et al. 18F-FDG-PET hyperactivity in Alzheimer’s disease cerebellum and primary olfactory cortex
Mieling Functional and structural changes in the progression of Alzheimer's disease: insights from human imaging
Depierreux Multimodal Imaging in Parkinson’s Disease: Exploring Iron–, Neuromelanin-Sensitive MRI and FDOPA PET Relationships
Eguiguren et al. Misdiagnosis of Frontotemporal Dementia in a Patient With Progressive Supranuclear Palsy: A Case Report and Volumetric Neuroimaging Application
Chen et al. From the Preclinical Stage
Pagulayan Madeleine L. Werhane, David P. Sheppard, Kathleen F. Pagulayan, Mark W. Bondi, and Lisa Delano‐Wood
Epstein White Matter Integrity, Alzheimer’s Pathology, and the Dopaminergic System in Aging-Related Cognitive Decline
Beyer Brain MRI changes in Parkinson’s disease

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241118

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20241118

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20250618

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250620

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250918

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20260119